Tempus AI, Inc. Class A Common Stock

Stock Chart, Company Information, and Scan Results

$60.67(as of Jul 17, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Tempus AI, Inc. Class A Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$60.67
Ticker SymbolTEM
ExchangeNasdaq
SectorHealthcare
IndustryHealth Information Services
Employees2,400
CountyUSA
Market Cap$9,675.5M
EBIDTA-658.2M
10-Day Moving Average58.52
P/E Ratio-10.14
20-Day Moving Average62.50
Forward P/E Ratio0.00
50-Day Moving Average62.63
Earnings per Share-5.16
200-Day Moving Average53.83
Profit Margin-26.60%
RSI47.59
Shares Outstanding168.1M
ATR3.93
52-Week High91.45
Volume14,253,136
52-Week Low31.36
Most Recent Support Level55.77
Book Value326.2M
Most Recent Resistance Level60.90
P/B Ratio22.03
Upper Keltner71.34
P/S Ratio8.95
Lower Keltner53.66
Debt-to-Equity Ratio71.34
Next Earnings Date08/12/2025
Cash Surplus-184.9M
Next Ex-Dividend DateUnknown

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Tempus AI, Inc. Class A Common Stock In Our Stock Scanner

example chart graphic
Date: Jul 17, 2025Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 17, 2025Scan Name: Moving Average CrossoverScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 17, 2025Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.